Literature DB >> 19756922

Recent trends of HER-2 examination and a new strategy of trastuzumab therapy for primary and metastatic breast cancer.

Masafumi Kurosumi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756922     DOI: 10.1007/s12282-009-0168-y

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


× No keyword cloud information.
  1 in total

Review 1.  Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma.

Authors:  Aaron M Gruver; Ziad Peerwani; Raymond R Tubbs
Journal:  J Clin Pathol       Date:  2010-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.